[The use of vasodilator agents in the therapy of chronic cardiac insufficiency].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008750:Methyldopa / Q000627:therapeutic use; D009566:Nitrates / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D002121:Calcium Channel Blockers; D004232:Diuretics; D009566:Nitrates; D014665:Vasodilator Agents; D009599:Nitroprusside; D008750:Methyldopa; D002216:Captopril; D003000:Clonidine; D011224:Prazosin
Uber die Anwendung von Vasodilatatoren in der Therapie der chronischen Herzinsuffizienz.